Items Tagged ‘Cardiovascular Disease’
May 26, 2022
Molecular mapping of the heart to predict disease susceptibility
Vulnerability to heart disease can be projected before symptoms occur, Mayo Clinic discovered in preclinical research. This proof-of-concept study revealed that heart muscle changes indicate who is vulnerable to disease later in life. These changes can be detected from blood samples through comprehensive protein and metabolite profiling. This exploratory mapping, conducted in the Marriott Family […]
Tags: Cardiovascular Disease, center for individualized medicine, Center for Regenerative Medicine, genomics, Heart Disease, individualized medicine
August 25, 2020
By Susan Murphy 
By Terri Malloy Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement― nonsurgical procedures to improve blood flow to the heart ― are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in […]
Tags: #cardiology, Cardiovascular Disease, individualized medicine, pharmacogenomics
July 1, 2020
By Susan Murphy
In recognition of their high impact work of advancing the field of genetic risk profiling for disease risk stratification, the National Institutes of Health (NIH) has awarded Mayo Clinic researchers Iftikhar Kullo, M.D. and Richard Sharp Ph.D. part of $75 million in funding over five years to improve the role of genomics in assessing and […]
Tags: Bioethics, Cardiovascular Disease, Genetics
February 13, 2018
Genetic cardiovascular disease: Is your family at risk?
With cardiovascular disease a leading cause of death, it’s fair to say that many people have been touched by this disorder. Maybe a family member died suddenly of a heart attack, or a friend suffered a disabling stroke. February is American Heart Month, a great time to talk about the precision approach Mayo Clinic Center […]
Tags: #Familial hypercholesterolemia, #FH, #Genetic risk, #High cholesterol, #Mayo Clinic Department of Cardioscular Diseases, #Mayo Clinic Department of Clinical Genomics, #Stroke, Cardiovascular Disease, Dr. Iftikhar Kullo, Genetic Testing, heart attack, Heart Disease
July 25, 2017
Workshops to offer practical ways to apply genomic medicine to improve care
By Sharon Rosen
Genetic testing is increasingly used in new ways to improve diagnosis and treatment for many conditions such as advanced cancers, cardiovascular diseases and gastrointestinal disorders. Post conference sessions at this year’s Individualizing Medicine 2017: Advancing Care Through Genomics are offered to help providers and patients learn how they can tap into these promising new technologies. […]
Tags: #cardiovascular genomics, #CIMCon17, #continuing medical education, #gastronintestinal diseases, #genetic disorders, #Individualizing Medicine 2017, #liver diseases, #Lysomal disease, #medical education, #rare genetic diseases, #rare genetic disorders, Cardiovascular Disease
November 14, 2013
Genomics Of Antiplatelet Heart Medication Study At Mayo Clinic
By AJ Montpetit
Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration’s recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate). The […]
Tags: antiplatelet, Cardiovascular Disease, center for individualized medicine, Genetic Testing, genome, genomics, heart medication, individualized medicine, mayo clinic, Naveen Pereira, personalized care, Personalized Medication